Iron Absorption From Regular, Biofortified and Post-harvest Fortified Pearl Millet
Comparison of Iron Absorption From Regular-iron, Iron Biofortified, and Post-harvest Iron-fortified Pearl Millet Using Multiple Meals in Young Women
1 other identifier
interventional
22
1 country
1
Brief Summary
Iron deficiency (ID) with or without anemia is still a main public health problem in sub-Saharan Africa and Southern Asia, especially in vulnerable population groups such as children below 5 years of age and women of reproductive age. The etiology of ID is multifactorial; but major causes are low iron dietary bioavailability and intake from monotonous cereal-based diets aggravated by chronic parasitic infections such as malaria and soil-transmitted helminthes. Approaches such as dietary diversification, supplementation with pharmacological iron doses, public health measures (e.g. deworming, malaria control) and food fortification with different iron compounds have notably reduced morbidity and mortality caused by ID but have not been universally successful. Biofortification is a new promising approach to combat micronutrient deficiencies such as ID. It is defined as the process of increasing the content and bioavailability of essential nutrients such as iron in crops by traditional plant breeding and/or genetic engineering. Pearl millet is a staple food for many people living in different areas of West Africa (e.g. Northern Benin) and India, two parts of the world, where ID is still widely prevalent. Therefore, pearl millet was one of the crops targeted for iron biofortification by HarvestPlus. To improve human iron status successfully, the additional iron gained through biofortification has to be at least as bioavailable as the iron in regular peal millet varieties. For that reason we are planning an iron absorption study where we will investigate the iron bioavailability from an iron-biofortified millet variety and compare it with the iron bioavailability from a regular-iron millet variety and from regular-iron millet fortified post-harvest with ferrous sulfate (FeSO4). Iron absorption will be determined by incorporation of labeled iron into erythrocytes, at least 14 days after the administration of the test meals containing labeled iron (stable isotope technique). The three different test meals based on 1) regular-iron, 2) iron-biofortified and 3) post-harvest iron-fortified millet will be administered as multiple meals i.e. each study participant will consume each test meal for a period of 5 days (2 portions/day; one in the morning, one for lunch). Twenty apparently healthy Beninese women with a low/marginal iron status (serum ferritin \< 25 ;g/L), non-anemic or mildly anemic (hemoglobin \>90 g/L), 18-30 years of age with a body weight \< 65 kg and normal body mass index will be included in the study. The results of the study will provide important insights on the iron bioavailability from regular, biofortified and post-harvest fortified staple crops such as pearl millet when feeding multiple meals as part of a more complex diet. The results can be applied to different meals based on pearl millet such as the West African millet pastes or the Indian flat breads.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 3, 2012
CompletedFirst Posted
Study publicly available on registry
July 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedNovember 8, 2012
November 1, 2012
2 months
July 3, 2012
November 7, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Iron isotope ratio in blood samples
Whole blood samples will be collected to measure the shift in iron isotope ratios 32 days after administration of isotopic label in the first test meal. First test meal on study days 1-5, Second test meal on study day 8-12 after a 2-day break, Third (last) test meal on study days 15-19 after a 2-day break, Measurement of iron isotopic shift in blood samples collected on study day 33 (14 days after the last test meal)
Study day 33 (32 days after administration of isotopic label in the first test meal/End of the study)
Study Arms (3)
regular-iron millet
EXPERIMENTALiron-biofortified millet
EXPERIMENTALPost-harvest iron-fortified millet
EXPERIMENTALInterventions
Labeled iron as FeSO4 will be added as a tag to a test meal consumed over 5 consecutive days for breakfast and for lunch
Labeled iron as FeSO4 will be added as a tag to a test meal consumed over 5 consecutive days for breakfast and for lunch
Labeled iron as FeSO4 will be added as a tag to a test meal consumed over 5 consecutive days for breakfast and for lunch
Eligibility Criteria
You may qualify if:
- Females of reproductive age, 18-30 years
- Low/marginal iron status (Hb \> 9.0 g/dl, SF \< 25 ;g/L)
- Maximum body weight 65 kg
- Normal body mass index (18.5-25 kg/m2)
- Obtained consent
You may not qualify if:
- Pregnancy or Lactating (assessed by pregnancy test)
- Fever (body temperature \>37.5 °C)
- Symptomatic malaria infection (positive blood smear for Plasmodium species + symptoms)
- Infection with soil-transmitted helminthes (positive stool samples and/or urine samples)
- Intake of mineral/vitamin supplements 2 weeks before and during the study
- Metabolic or gastrointestinal disorders, eating disorders or food allergy
- Regular intake of medication
- Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 6 months
- Currently participating in another clinical trial or having participated in another clinical trial during the last 3 months prior to the beginning of this study
- Former participation in a study involving administration of iron stable isotopes
- Subject who cannot be expected to comply with study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swiss Federal Institute of Technologylead
- Université d'Abomey-Calavicollaborator
Study Sites (1)
Hopital du Zone de Natitingou
Natitingou, Atakora Department, Benin
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
July 3, 2012
First Posted
July 6, 2012
Study Start
July 1, 2012
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
November 8, 2012
Record last verified: 2012-11